Sarah Frier is an Editor in charge of Big Tech coverage at Bloomberg. She focuses on consumer tech and emerging technologies, including AI platforms, computer vision, generative AI, and robotics, while also exploring their impact on the global economy. Frier's work has been featured in prominent publications such as The Washington Post, Fortune, and TIME.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .
Qualcomm Inc. said it has renewed its global licensing pact with Apple Inc., starting April 2027.
Nscale, the artificial intelligence infrastructure company, hired a long-time Meta Platforms Inc. executive to be its chief operating officer, to accelerate a rapid expansion connected to its upcoming initial public offering, according to a person familiar with the matter.
(Bloomberg) -- Nscale, the artificial intelligence infrastructure company, hired a long-time Meta Platforms Inc. executive to be its chief operating
By: Matt Day, Liam Knox, Sarah Frier
Indian IT firms, including TCS, Infosys, Wipro and HCLTech, are among the tech firms suspended from the Permanent Labor Certification Program.
By: Ryan Vlastelica, Sarah Frier
When measuring the race between artificial intelligence leaders OpenAI and Anthropic PBC, investors have run into a problem: The two private companies calculate a closely watched revenue figure differently.
By: Sarah Frier, Riley Griffin
The Muse Wonder model will be a key test for Meta’s expensive and rebuilt superintelligence team.
Meta Platforms Inc. said it has agreed to spend about $825 billion in the future on various leases and contracts, many of them related to computing power and infrastructure for artificial intelligence.
The commitments include $355.7bn in future lease obligations and $454.5bn in non-cancellable contracts.
Meta is seeking to raise as much as $95bn (€85bn) from selling stock, as it taps investors for support in the race to lead the development of artificial intelligence.
Ferring Pharmaceuticals has signed a $1.4 billion deal to buy Gameto Inc., a biotech company best known for its product that aims to improve egg freezing for women.
